Literature DB >> 25452278

Use of an endogenous plasmid locus for stable in trans complementation in Borrelia burgdorferi.

Irene N Kasumba1, Aaron Bestor2, Kit Tilly2, Patricia A Rosa2.   

Abstract

Targeted mutagenesis and complementation are important tools for studying genes of unknown function in the Lyme disease spirochete Borrelia burgdorferi. A standard method of complementation is reintroduction of a wild-type copy of the targeted gene on a shuttle vector. However, shuttle vectors are present at higher copy numbers than B. burgdorferi plasmids and are potentially unstable in the absence of selection, thereby complicating analyses in the mouse-tick infectious cycle. B. burgdorferi has over 20 plasmids, with some, such as linear plasmid 25 (lp25), carrying genes required by the spirochete in vivo but relatively unstable during in vitro cultivation. We propose that complementation on an endogenous plasmid such as lp25 would overcome the copy number and in vivo stability issues of shuttle vectors. In addition, insertion of a selectable marker on lp25 could ensure its stable maintenance by spirochetes in culture. Here, we describe the construction of a multipurpose allelic-exchange vector containing a multiple-cloning site and either of two selectable markers. This suicide vector directs insertion of the complementing gene into the bbe02 locus, a site on lp25 that was previously shown to be nonessential during both in vitro and in vivo growth. We demonstrate the functional utility of this strategy by restoring infectivity to an ospC mutant through complementation at this site on lp25 and stable maintenance of the ospC gene throughout mouse infection. We conclude that this represents a convenient and widely applicable method for stable gene complementation in B. burgdorferi.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25452278      PMCID: PMC4292500          DOI: 10.1128/AEM.03657-14

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  54 in total

1.  New pUC-derived cloning vectors with different selectable markers and DNA replication origins.

Authors:  J Vieira; J Messing
Journal:  Gene       Date:  1991-04       Impact factor: 3.688

2.  Lyme disease-a tick-borne spirochetosis?

Authors:  W Burgdorfer; A G Barbour; S F Hayes; J L Benach; E Grunwaldt; J P Davis
Journal:  Science       Date:  1982-06-18       Impact factor: 47.728

3.  New antibiotic resistance cassettes suitable for genetic studies in Borrelia burgdorferi.

Authors:  Abdallah F Elias; James L Bono; John J Kupko; Philip E Stewart; Jonathan G Krum; Patricia A Rosa
Journal:  J Mol Microbiol Biotechnol       Date:  2003

4.  aadA confers streptomycin resistance in Borrelia burgdorferi.

Authors:  Kristi L Frank; Sharyl F Bundle; Michele E Kresge; Christian H Eggers; D Scott Samuels
Journal:  J Bacteriol       Date:  2003-11       Impact factor: 3.490

5.  gyrB mutations in coumermycin A1-resistant Borrelia burgdorferi.

Authors:  D S Samuels; R T Marconi; W M Huang; C F Garon
Journal:  J Bacteriol       Date:  1994-05       Impact factor: 3.490

6.  Experimental assessment of the roles of linear plasmids lp25 and lp28-1 of Borrelia burgdorferi throughout the infectious cycle.

Authors:  Dorothee Grimm; Christian H Eggers; Melissa J Caimano; Kit Tilly; Philip E Stewart; Abdallah F Elias; Justin D Radolf; Patricia A Rosa
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

7.  Outer-surface protein C of the Lyme disease spirochete: a protein induced in ticks for infection of mammals.

Authors:  Dorothee Grimm; Kit Tilly; Rebecca Byram; Philip E Stewart; Jonathan G Krum; Dawn M Bueschel; Tom G Schwan; Paul F Policastro; Abdallah F Elias; Patricia A Rosa
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-17       Impact factor: 11.205

8.  Plasmid stability during in vitro propagation of Borrelia burgdorferi assessed at a clonal level.

Authors:  Dorothee Grimm; Abdallah F Elias; Kit Tilly; Patricia A Rosa
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

9.  Changes in infectivity and plasmid profile of the Lyme disease spirochete, Borrelia burgdorferi, as a result of in vitro cultivation.

Authors:  T G Schwan; W Burgdorfer; C F Garon
Journal:  Infect Immun       Date:  1988-08       Impact factor: 3.441

10.  Global repression of host-associated genes of the Lyme disease spirochete through post-transcriptional modulation of the alternative sigma factor RpoS.

Authors:  Daniel P Dulebohn; Beth M Hayes; Patricia A Rosa
Journal:  PLoS One       Date:  2014-03-26       Impact factor: 3.240

View more
  6 in total

Review 1.  Genetic Manipulation of Borrelia Spp.

Authors:  Dan Drecktrah; D Scott Samuels
Journal:  Curr Top Microbiol Immunol       Date:  2018       Impact factor: 4.291

2.  Borrelia burgdorferi bbk13 Is Critical for Spirochete Population Expansion in the Skin during Early Infection.

Authors:  George F Aranjuez; Hunter W Kuhn; Philip P Adams; Mollie W Jewett
Journal:  Infect Immun       Date:  2019-04-23       Impact factor: 3.441

Review 3.  Genetic Manipulation of Borrelia.

Authors:  Patricia A Rosa; Mollie W Jewett
Journal:  Curr Issues Mol Biol       Date:  2020-12-10       Impact factor: 2.081

4.  Plasmid diversity and phylogenetic consistency in the Lyme disease agent Borrelia burgdorferi.

Authors:  Sherwood R Casjens; Eddie B Gilcrease; Marija Vujadinovic; Emmanuel F Mongodin; Benjamin J Luft; Steven E Schutzer; Claire M Fraser; Wei-Gang Qiu
Journal:  BMC Genomics       Date:  2017-02-15       Impact factor: 3.969

5.  A CRISPR interference platform for selective downregulation of gene expression in Borrelia burgdorferi.

Authors:  Constantin N Takacs; Molly Scott; Yunjie Chang; Zachary A Kloos; Irnov Irnov; Patricia A Rosa; Jun Liu; Christine Jacobs-Wagner
Journal:  Appl Environ Microbiol       Date:  2020-11-30       Impact factor: 4.792

Review 6.  The Consistent Tick-Vertebrate Infectious Cycle of the Lyme Disease Spirochete Enables Borrelia burgdorferi To Control Protein Expression by Monitoring Its Physiological Status.

Authors:  Brian Stevenson; Andrew C Krusenstjerna; Tatiana N Castro-Padovani; Christina R Savage; Brandon L Jutras; Timothy C Saylor
Journal:  J Bacteriol       Date:  2022-04-05       Impact factor: 3.476

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.